Trials / Completed
CompletedNCT05827341
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study focuses on the population of malignant lymphoma patients who are also in clinical research. Through a real world cross-sectional survey of infection and death risk during the COVID-19 pandemic in Guangzhou from December 2022 to January 2023, this study aims to clarify the risk, level and mortality of lymphoma patients infected with COVID-19 during their clinical research, and provide necessary research data for Chinese lymphoma patients during the COVID-19 pandemic,
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention needed |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-01-31
- Completion
- 2023-05-15
- First posted
- 2023-04-25
- Last updated
- 2023-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05827341. Inclusion in this directory is not an endorsement.